390 related articles for article (PubMed ID: 21536937)
1. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T
Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
Gershon A; Croxford R; Calzavara A; To T; Stanbrook MB; Upshur R; Stukel TA
JAMA Intern Med; 2013 Jul; 173(13):1175-85. PubMed ID: 23689820
[TBL] [Abstract][Full Text] [Related]
3. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
Gershon AS; Campitelli MA; Croxford R; Stanbrook MB; To T; Upshur R; Stephenson AL; Stukel TA
JAMA; 2014 Sep; 312(11):1114-21. PubMed ID: 25226477
[TBL] [Abstract][Full Text] [Related]
4. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
Gershon AS; Wang L; To T; Luo J; Upshur RE
COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
6. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
Blais L; Forget A; Ramachandran S
Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
[TBL] [Abstract][Full Text] [Related]
7. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
[TBL] [Abstract][Full Text] [Related]
8. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
Hanania NA
Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
[TBL] [Abstract][Full Text] [Related]
9. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
10. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
Lee TA; Schumock GT; Bartle B; Pickard AS
Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
[TBL] [Abstract][Full Text] [Related]
11. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
Chen AM; Bollmeier SG; Finnegan PM
Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
[TBL] [Abstract][Full Text] [Related]
12. Medications for COPD: a review of effectiveness.
Grimes GC; Manning JL; Patel P; Via RM
Am Fam Physician; 2007 Oct; 76(8):1141-8. PubMed ID: 17990836
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.
Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ;
Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710
[TBL] [Abstract][Full Text] [Related]
14. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.
Tashkin DP
Expert Rev Respir Med; 2010 Jun; 4(3):279-89. PubMed ID: 20524910
[TBL] [Abstract][Full Text] [Related]
15. Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease?
Reddy CB; Kanner RE
Drugs Aging; 2007; 24(8):615-28. PubMed ID: 17702532
[TBL] [Abstract][Full Text] [Related]
16. Triple therapy for the management of COPD: a review.
Gaebel K; McIvor RA; Xie F; Blackhouse G; Robertson D; Assasi N; Hernandez P; Goeree R
COPD; 2011 Jun; 8(3):206-43. PubMed ID: 21513437
[TBL] [Abstract][Full Text] [Related]
17. The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease.
Beeh KM; Beier J
Adv Ther; 2010 Mar; 27(3):150-9. PubMed ID: 20411368
[TBL] [Abstract][Full Text] [Related]
18. Common lung conditions: chronic obstructive pulmonary disease.
Delzell JE
FP Essent; 2013 Jun; 409():23-31. PubMed ID: 23767419
[TBL] [Abstract][Full Text] [Related]
19. Inhaled Long-acting Anticholinergics and Urinary Tract Infection in Individuals with COPD.
Gershon AS; Newman AM; Fischer HD; Austin PC; Daneman N; Bell CM; Stephenson AL; Gill SS; Vozoris NT; Rochon PA
COPD; 2017 Feb; 14(1):105-112. PubMed ID: 27732117
[TBL] [Abstract][Full Text] [Related]
20. Contemporary management of chronic obstructive pulmonary disease: scientific review.
Sin DD; McAlister FA; Man SF; Anthonisen NR
JAMA; 2003 Nov; 290(17):2301-12. PubMed ID: 14600189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
